Search Results Search Sort by RelevanceMost Recent Medicine and Society Apr 2024 How Should Critical Medications Be Rationed During Shortages? Erin R. Fox, PharmD, MHA and Matthew K. Wynia, MD, MPH Recent increases in the frequency of shortages require more rationing by clinicians. AMA J Ethics. 2024;26(4):E334-340. doi: 10.1001/amajethics.2024.334. Medicine and Society Oct 2019 Which Ethical Considerations Should Inform Hospice Decisions About Caring for Patients With Obesity? Chithra R. Perumalswami, MD, MSc, Brycin D. Hanslits, and Susan D. Goold, MD, MA, MHSA Current evidence suggests how hospice and palliative care clinicians can help advocate for high-quality, end-of-life care for patients with obesity. AMA J Ethics. 2019;21(10):E873-878. doi: 10.1001/amajethics.2019.873. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Medicine and Society Apr 2024 How Should Critical Medications Be Rationed During Shortages? Erin R. Fox, PharmD, MHA and Matthew K. Wynia, MD, MPH Recent increases in the frequency of shortages require more rationing by clinicians. AMA J Ethics. 2024;26(4):E334-340. doi: 10.1001/amajethics.2024.334.
Medicine and Society Oct 2019 Which Ethical Considerations Should Inform Hospice Decisions About Caring for Patients With Obesity? Chithra R. Perumalswami, MD, MSc, Brycin D. Hanslits, and Susan D. Goold, MD, MA, MHSA Current evidence suggests how hospice and palliative care clinicians can help advocate for high-quality, end-of-life care for patients with obesity. AMA J Ethics. 2019;21(10):E873-878. doi: 10.1001/amajethics.2019.873.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.